Cargando…
1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre
Autores principales: | Wu, A., Sng, C.C.T., Benafif, S., Chopra, N., Galazi, M., Lee, A.J.X., Ottaviani, D., Soosaipillai, G.B., Wong, Y.N.S., Shaw, H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506396/ http://dx.doi.org/10.1016/j.annonc.2020.08.1768 |
Ejemplares similares
-
1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre
por: Sng, C.C.T., et al.
Publicado: (2020) -
1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital
por: Sinclair, A., et al.
Publicado: (2021) -
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
por: Sng, Christopher C. T., et al.
Publicado: (2020) -
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
por: Wong, Yien Ning Sophia, et al.
Publicado: (2021) -
1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection
por: Soosaipillai, G.B., et al.
Publicado: (2020)